NASDAQ:JAZZ

Jazz Pharmaceuticals Stock News

etoro logo Buy JAZZ
*Your capital is at risk
$230.93
+4.81 (+2.13%)
At Close: Jun 03, 2026
The consensus price target hints at a 51.7% upside potential for Jazz (JAZZ). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate rev
While the top- and bottom-line numbers for Jazz (JAZZ) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wa
Jazz Pharmaceuticals (JAZZ) came out with quarterly earnings of $4.51 per share, beating the Zacks Consensus Estimate of $4.46 per share. This compares to earnings of $4.30 per share a year ago.

3 Biotech Stocks You'll Regret Not Buying Soon

11:37pm, Tuesday, 08'th Aug 2023
The biotech industry proved itself resilient in the face of the COVID-19 pandemic. With research from Mckinsey, venture capitalist ( VC ) companies increased investments from 2,200 in 2016 to 3,100 in
Jazz Pharmaceuticals (JAZZ) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Deep Track Capital, LP (Trades, Portfolio), a prominent investment firm, recently made a significant move in the stock market by acquiring a new stake in Terns Pharmaceuticals Inc. This article will d

3 Stocks to Buy as Recession Looks Unlikely

11:42am, Thursday, 27'th Jul 2023
These are opportunities to buy at reasonable valuations.
Jazz Pharmaceuticals' current valuation is significantly lower than the sector average, despite strong margins and a positive growth outlook, presenting a potential investment opportunity. The company
Unlock hidden value and drive higher returns to your portfolio with high earnings yield stocks like PLAY, URBN, KELYA, LTHM and JAZZ.
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Jazz Pharmaceuticals (JAZZ) and Zoetis (ZTS). But which of these two stocks offers value investors a bette
While a very few are just now coming off of all-time highs (Nvidia, among others), some are recently all the way down to new 52-week lows.
Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock?
Do you intend to invest in marijuana stocks in 2023?  Over the last decade, the cannabis industry has grown incredibly, transitioning from a taboo subject to a respectable and wealthy corporate secto
DUBLIN , May 30, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the 2023 Goldman Sachs Global Healthcare Conference. Company manageme
Zanidatamab data to be featured in oral presentation at ASCO 2023 Webcast to follow on June 2, 2023 at 6:45 p.m. CT DUBLIN , May 25, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) will
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE